Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Statistics

Total Valuation

GHSE:IIL has a market cap or net worth of GHS 10.98 million. The enterprise value is 18.30 million.

Market Cap	10.98M
Enterprise Value	18.30M

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

GHSE:IIL has 274.41 million shares outstanding.

Current Share Class	274.41M
Shares Outstanding	274.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-3.69%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.44
PB Ratio	0.69
P/TBV Ratio	0.69
P/FCF Ratio	1.75
P/OCF Ratio	1.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.45, with an EV/FCF ratio of 2.92.

EV / Earnings	-28.46
EV / Sales	0.73
EV / EBITDA	12.45
EV / EBIT	22.38
EV / FCF	2.92

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.55.

Current Ratio	0.83
Quick Ratio	0.58
Debt / Equity	0.55
Debt / EBITDA	5.99
Debt / FCF	1.41
Interest Coverage	5.70

Financial Efficiency

Return on equity (ROE) is -3.87% and return on invested capital (ROIC) is 1.85%.

Return on Equity (ROE)	-3.87%
Return on Assets (ROA)	1.12%
Return on Invested Capital (ROIC)	1.85%
Return on Capital Employed (ROCE)	4.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.55
Inventory Turnover	2.17

Taxes

In the past 12 months, GHSE:IIL has paid 157,590 in taxes.

Income Tax	157,590
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.00% in the last 52 weeks. The beta is 0.18, so GHSE:IIL's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-20.00%
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	7.19
Average Volume (20 Days)	15,170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GHSE:IIL had revenue of GHS 24.94 million and -642,888 in losses. Loss per share was -0.00.

Revenue	24.94M
Gross Profit	11.55M
Operating Income	817,491
Pretax Income	-485,298
Net Income	-642,888
EBITDA	1.47M
EBIT	817,491
Loss Per Share	-0.00

Balance Sheet

The company has 1.49 million in cash and 8.81 million in debt, giving a net cash position of -7.32 million or -0.03 per share.

Cash & Cash Equivalents	1.49M
Total Debt	8.81M
Net Cash	-7.32M
Net Cash Per Share	-0.03
Equity (Book Value)	15.91M
Book Value Per Share	0.06
Working Capital	-4.14M

Cash Flow

In the last 12 months, operating cash flow was 8.16 million and capital expenditures -1.90 million, giving a free cash flow of 6.26 million.

Operating Cash Flow	8.16M
Capital Expenditures	-1.90M
Free Cash Flow	6.26M
FCF Per Share	0.02

Margins

Gross margin is 46.31%, with operating and profit margins of 3.28% and -2.58%.

Gross Margin	46.31%
Operating Margin	3.28%
Pretax Margin	-1.95%
Profit Margin	-2.58%
EBITDA Margin	5.89%
EBIT Margin	3.28%
FCF Margin	25.09%

Dividends & Yields

GHSE:IIL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.86%
FCF Yield	57.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GHSE:IIL has an Altman Z-Score of 0.86 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.86
Piotroski F-Score	4